The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of VH 3-23 and 3-30/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy

Clinical Immunology

Volumn 99, Issue 1, 2001, Pages 18-29

  Leucht, Stephan ^a   Uttenreuther Fischer, Martina M ^a   Gaedicke, Gerhard ^a   Fischer, Peter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Antiidiotype; B cell; Complementarity determining region; Immunoglobulin; Phage display; Superantigen

Indexed keywords

ACETYLSALICYLIC ACID; AMINO ACID; B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NUCLEOTIDE; SUPERANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; CASE REPORT; CHILD; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; HUMAN; MUCOCUTANEOUS LYMPH NODE SYNDROME; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; UNINDEXED SEQUENCE;

EID: 0035050651     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5004     Document Type: Article

References (49)

1. Overview of pharmacological treatment of Kawasaki disease
2. Kawasaki disease
3. Kawasaki disease: Update on diagnosis, treatment and a still controversial etiology
4. Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease
5. Kawasaki disease. With particular emphasis on arterial lesions
6. Soluble CD23 antigen in Kawasaki disease and other acute febrile illnesses
7. Summary and abstracts of the Sixth International Kawasaki Disease Symposium - February 11-14, 1999, Waikoloa, Hawaii, USA
8. Superantigens in the aetiology of Kawasaki disease
9. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
10. Lymphocyte subsets in patients with idiopathic thrombocytopenic purpura during high-dose gamma globulin therapy
11. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens
12. Antigenic recognition by intravenous gamma-globulin of selected bacteria isolated from throats of patients with Kawasaki syndrome
13. Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura
14. Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin
15. Towards a network theory of the immune system
16. Immunoglobulins and the regulation of autoimmunity through the immune network
17. Assembly of combinatorial antibody libraries on phage surfaces: The gene III site
18. A surface expression vector for antibody screening
19. Making antibody fragments using phage display libraries
20. Immunization of hu-PBL-SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries
21. IgG rheumatoid factors isolated by surface displaying phage library technique
22. Possible presence of enhancing antibodies in idiopathic thrombocytopenic purpura
23. Genetic origin of IgG antibodies cloned by phage display and antiidiotypic panning from three patients with autoimmune thrombocytopenia
24. Platelet reactive IgG antibodies cloned by phage display and panning with IVIG from three patients with autoimmune thrombocytopenia
25. H3 gene use in phage displayed Fab that are selected by IVIG
26. Genetic origin of IgG antibodies cloned by phage display and antiidiotypic panning from three patients with autoimmune thrombocytopenia
27. IVIG-bound IgG and IgM cloned by phage display from a healthy individual reveal the same restricted germ-line gene origin as in autoimmune thrombocytopenia
28. Combinatorial immunoglobulin libraries on the surface of phage (Phabs): Rapid selection of antigen-specific Fabs
29. Rapid simultaneous screening for DNA integrity and antigen specificity of clones selected by phage display
30. Human antinicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from Myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies
31. B-cell superantigens
32. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: Structural basis for recognition of B-cell receptors and superantigen activity
33. The human immunoglobulin V-H repertoire
34. The frequency of homozygous deletion of a developmentally regulated Vh gene (Humhv3005) is increased in patients with chronic idiopathic thrombocytopenic purpura
35. Non-stochastic utilization of Ig V region genes in unselected human peripheral B cells
36. The human heavy chain Ig V region gene repertoire is biased at all stages of B cell ontogeny, including early pre-B cells
37. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire
38. Intravenous immunoglobulin (i.v. IgG) for previously treated acute or for chronic idiopathic thrombocytopenic purpura (ITP) in childhood: A prospective multicenter study
39. Molecular selection of human antibodies with an unconventional bacterial B cell antigen
40. Anti-idiotypic antibody D12 and superantigen SPA both interact with human V(H)3-encoded antibodies on the external face of the heavy chain involving FR1, CDR2 and FR3
41. Staphylococcal enterotoxin A induces survival of V(H)3-expressing human B cells by binding to the V-H region with low affinity
42. CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences
43. Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig
44. Structural basis of the gp120 superantigen-binding site on human immunoglobulins
45. Characterization of superantigen-induced clonal deletion with a novel clan III-restricted avian monoclonal antibody: Exploiting evolutionary distance to create antibodies specific for a conserved VH region surface
46. Superantigen properties of a human sialoprotein involved in gut-associated immunity